SpirAir is a medical technology company focused on developing minimally invasive solutions for Ear, Nose, and Throat (ENT) care that improve patient outcomes and clinical workflows. The company’s mission is to provide innovative therapies that help clinicians deliver better care with less disruption and faster recovery for patients. 

Spirair emerged from the Stanford Biodesign Innovation Fellowship, where its founders identified a critical need for improved treatment options for conditions like nasal septal deviation and the healing process following sinus surgery. The company’s first products — SeptAlign™ and TurbAlign™ — are bioabsorbable implants designed to support structural correction and healing in nasal anatomy with minimally invasive techniques. 

• SeptAlign™ provides a minimally invasive option for mechanically correcting minor nasal septal deviations, delivering support to the cartilage and dissolving over time. nsmedicaldevices.com

• TurbAlign™ has received FDA clearance as a novel implant that helps keep nasal passages open after sinus surgery by separating key structures during the healing phase. Spirair

With a growing leadership team and advancing clinical programs, Spirair is positioned at the intersection of medical innovation and improved patient experience, enabling ENT specialists to incorporate new therapeutic options into standard treatment protocols.